Ipca Laboratories Limited
IPCALAB
शेयरों में रैंक
#3270
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
शेयर मूल्य
$21.24
मार्केट कैप
$5.39B
बदलाव (1 दिन)
6.09%
बदलाव (1 वर्ष)
45.94%
देश
IN
व्यापार Ipca Laboratories Limited (IPCALAB)
श्रेणी
Healthcare
Ipca Laboratories Limited (IPCALAB) के लिए राजस्व
Jun 2026 में राजस्व TTM: $1.12B
Ipca Laboratories Limited की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $1.12B है। 2024 में, कंपनी ने $924.15M का राजस्व अर्जित किया जो 2023 के $760.29M के राजस्व से की वृद्धि है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Ipca Laboratories Limited के लिए 2005 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
| वर्ष | राजस्व | परिवर्तन |
|---|---|---|
| 2026 (TTM) | $1.12B | 6.89% |
| 2025 | $1.05B | 13.12% |
| 2024 | $924.15M | 21.55% |
| 2023 | $760.29M | -1.02% |
| 2022 | $768.09M | 3.73% |
| 2021 | $740.50M | 19.97% |
| 2020 | $617.22M | 13.54% |
| 2019 | $543.63M | 7.74% |
| 2018 | $504.56M | 3.67% |
| 2017 | $486.70M | 12.46% |
| 2016 | $432.77M | -14.12% |
| 2015 | $503.92M | -7.96% |
| 2014 | $547.51M | 5.75% |
| 2013 | $517.74M | 11.30% |
| 2012 | $465.16M | 9.12% |
| 2011 | $426.30M | 22.77% |
| 2010 | $347.24M | 37.32% |
| 2009 | $252.88M | -3.75% |
| 2008 | $262.72M | 21.27% |
| 2007 | $216.64M | 27.04% |
| 2006 | $170.53M | 9.66% |
| 2005 | $155.51M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
| कंपनी | राजस्व | राजस्व में अंतर | देश |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 491.67% |
IN
|
